Dravet Syndrome
Symptoms, Doctors, Treatments, Advances & More

Dravet Syndrome Overview

Save information for later
Sign Up

Learn About Dravet Syndrome

What is the definition of Dravet Syndrome?
Dravet syndrome is the most severe of a group of conditions known as SCN1A-related seizure disorders. Symptoms include seizures which first occur in infancy that are often triggered by high temperatures (febrile seizures). In childhood, many types of seizures may occur and they may increase in frequency. Seizures may be difficult to treat. Other symptoms include loss of motor skills, intellectual disability, speech impairment, and difficulty with movement. Most cases of Dravet syndrome occur when the SCN1A gene is not working correctly. It can be inherited in an autosomal dominant pattern, but most people with Dravet syndrome do not have a family history of the condition. Diagnosis is based on a clinical exam, medical history, and the results of genetic testing.
What are the alternative names for Dravet Syndrome?
  • Dravet syndrome
  • Myoclonic epilepsy, severe, of infancy
  • SME
  • SMEI
  • Severe Myoclonic Epilepsy of Infancy
Who are the top Dravet Syndrome Local Doctors?
Rajdeep Singh
Distinguished in Dravet Syndrome
Dr. Rajdeep Singh
Neurology
Distinguished in Dravet Syndrome
Dr. Rajdeep Singh
Neurology

Atrium Health Neurology Specialty Care

1225 Harding Place, Suite 4200, 
Charlotte, NC 
704-468-0101
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajdeep Singh is a Neurologist in Charlotte, North Carolina. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Dravet Syndrome. His top areas of expertise are Seizures, Memory Loss, Dravet Syndrome, and Epilepsy. Dr. Singh is currently accepting new patients.

Elite in Dravet Syndrome
Dr. Jack Parent
Neurology
Elite in Dravet Syndrome
Dr. Jack Parent
Neurology

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor, MI 
734-936-9020
Languages Spoken:
English
See accepted insurances

Jack Parent is a Neurologist in Ann Arbor, Michigan. Dr. Parent is rated as an Elite provider by MediFind in the treatment of Dravet Syndrome. His top areas of expertise are Myoclonic Epilepsy, Epilepsy, Epilepsy with Myoclonic-Atonic Seizures, and Dravet Syndrome.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Dravet Syndrome
Dr. Orrin Devinsky
Neurology
Elite in Dravet Syndrome
Dr. Orrin Devinsky
Neurology

Werner K Doyle M.D. PC

223 E 34th St, 
New York, NY 
212-263-8870
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Orrin Devinsky is a Neurologist in New York, New York. Dr. Devinsky is rated as an Elite provider by MediFind in the treatment of Dravet Syndrome. His top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.

View All Doctors
What are the latest Dravet Syndrome Clinical Trials?
EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome
EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome
Enrollment Status: Recruiting
Publish Date: February 09, 2026
Intervention Type: Drug, Other
Study Phase: Phase 3

Summary: The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
Enrollment Status: Recruiting
Publish Date: February 03, 2026

Summary: Dravet syndrome with SCN1A gene mutation is a developmental and epileptic encephalopathy characterized by treatment-resistant epilepsy and global developmental delay. Despite the considerable attention recently Dravet syndrome (DS) in drug development, studies characterising the progression of the neurodevelopmental phenotype over time remain limited. In particular, many previous studies of natura...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center